Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01372566 · ClinicalTrials.gov registry record · Phase 1
Effect of Platelet Rich Plasma on Photoaged Skin
A Phase 1 study of Photoaging, sponsored by Northwestern University.
- Active
- Registry status
- Phase 1
- Development phase
- 23
- Enrollment target
- 1
- Study location
NCT01372566: Active Phase 1 study of Photoaging, sponsored by Northwestern University.
NCT01372566 is a Phase 1 study of Photoaging that is active but no longer recruiting, run by Northwestern University. The registered enrollment target is 23 participants, below the 30-participant average among 14 other Photoaging trials with a reported enrollment target (23% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01372566, a Phase 1 study of Photoaging, is active but no longer recruiting, sponsored by Northwestern University.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 1
- Development phase
- 23 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to assess the safety, tolerability and effectiveness of platelet rich plasma in the treatment of photoaged skin. This study will be divided into two parts. The first part will assess the safety and tolerability of platelet rich plasma injections as compared to sterile saline injections in subjects' arm with six months follow-up. The second part will assess the effect of platelet rich plasma on the appearance of facial skin in a split face study with platelet rich plasma injections on one side of the face and sterile saline on the other. Outcomes will be recorded for twelve months.
Conditions Studied
Interventions
- DEVICE Harvest PRP Separation System
- OTHER Sterile Saline injection
Study Locations (1)
Illinois
- Northwestern University Dermatology - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2011-05 |
| Est. Completion | 2025-12 |
| Phase | Phase 1 |
What the registry record for NCT01372566 still lists
NCT01372566 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 23 participants, a relatively small participant target, below the 30-participant average among 14 other Photoaging trials with a reported enrollment target (23% lower).
The record links to 1 condition, with Photoaging appearing as the primary indexed condition, and to 2 interventions - of which Harvest PRP Separation System is the first listed.
NCT01372566 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT01372566 about?
NCT01372566 is a clinical study titled "Effect of Platelet Rich Plasma on Photoaged Skin". The goal of this study is to assess the safety, tolerability and effectiveness of platelet rich plasma in the treatment of photoaged skin. This study will be divided into two parts. The first part will assess the safety and tolerability of platelet rich plasma injections as compared to sterile salin...
What is the current status of trial NCT01372566?
This trial is currently active not recruiting. It is a Phase 1 study. The enrollment target is 23 participants. The study started on 2011-05. Estimated completion is 2025-12.
What conditions does trial NCT01372566 study?
This clinical trial studies the following conditions: Photoaging.
What interventions are being tested in trial NCT01372566?
The interventions under investigation include: Harvest PRP Separation System (DEVICE), Sterile Saline injection (OTHER).
Who is sponsoring clinical trial NCT01372566?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01372566 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Photoaging
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01372566's enrollment target sits among peer trials
23 10th of 14 higher than 5 of 14 other Photoaging trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Photoaging trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Investigating Age Dependence of Fibroblast and Extracellular Matrix Responses to Cross-linked Hyaluronic Acid Filler in Human Skin
RECRUITING · NA
-
Evaluation of the Effects of a Biostimulator and Dermal Fillers for Cheek Augmentation and Contour Deficiencies
ACTIVE NOT RECRUITING · NA
-
Evaluating Procedure Pairing of a Post-Procedure Cream Versus a Comparator in Patients Treated With a Radiofrequency Microneedling for Facial Rejuvenation
COMPLETED · NA
-
Comparison of the Cosmetic Effects of Bakuchiol and Retinol
COMPLETED · Early Phase 1
-
Double-Blind Study Determining the Efficacy of CannaXR in Decreasing UVA Premutagenic and Photoaging Markers
COMPLETED · NA
-
Safety and Effectiveness of the CLEAR + BRILLIANT TOUCH(R) Diode Laser 1440-nm and 1927-nm Combination Wavelength Treatment
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03616041 · 23 participants
Capsule Endoscopy for Severe Hematochezia
- NCT04348747 · 23 participants · Phase 2
Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer
- NCT04587687 · 23 participants · Phase 2
Brentuximab Vedotin and Bendamustine for the Treatment of Relapsed or Refractory Follicular Lymphoma
- NCT04715022 · 23 participants · Phase 1
Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia